Clinical Trials · NCT07775846
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Huijie Zhang
- Enrollment
- 820
- Start date
- Sep 2026
- Locations
- 1 site, China
- Primary endpoint
- Relative Change From Baseline in Urine Albumin-to-Creatinine Ratio (UACR) at Month 6